Coverage
-
September 04, 2019
A California federal judge has partly granted Lannett's bid to dismiss a suit accusing it of misleading consumers into believing that its cocaine-based anesthetic, on the market since at least 2008, had received government approval, but he also allowed false advertising claims against the company to continue.
1 other articles on this case.
View all »